reSee.it - Related Video Feed

Vaccines are crucial for public health. There will be new vaccines developed, including for TB, malaria, and HIV. Misinformation about vaccines is a problem, especially in the US. We need to invest in vaccinations, as it has a significant return on investment. Life will not fully return to normal until the global population is vaccinated. We must prepare for future pandemics.

Vaccines are seen as magical but expectations should be tempered. Pfizer's vaccine is 95% effective, but efficacy drops over time. Boosters may be needed annually. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but we must adapt.

Vaccines must be carefully studied to ensure they do not worsen infections. Past vaccines, like the respiratory syncytial virus vaccine for children, have unexpectedly made things worse. Similarly, an HIV vaccine increased infection risk in some cases. It's crucial to conduct thorough studies in high-risk populations to understand how vaccines truly impact infections before widespread use.

Pfizer announced its vaccine trial for 12-15 year olds was 100% effective in preventing infection. This news could impact school reopenings. Dr. Purnell, a public health physician, noted the mRNA vaccine technology is promising, with efficacy rates even higher than in adults. The 100% effectiveness is unprecedented and a significant development.

The AstraZeneca vaccine is 100% effective against hospitalization and death, a crucial statistic that needs more attention. This information has only recently become available, and while the 70% effectiveness rate is also impressive, the focus should be on the strong protection it offers against severe outcomes.

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

Medicines we know from the COVID vaccine. Very effective, very welcome. The logistics around that vaccine were not straightforward because of the new technologies. We're talking about countries here that do not have advanced

In 2022, over 14 million children missed vaccinations. Collaborating with partners like Gavi and UNICEF, we aim to reduce this number by 2030. However, we face significant challenges from anti-vaccine movements, which have gained traction, especially during COVID-19. It's crucial to strategize and push back against misinformation, as vaccines are effective and beneficial for both children and adults. We need to take a more assertive stance in countering the narratives propagated by anti-vaxxers to protect public health.

Remdesivir can be used intravenously for 28 days, while children aged 12 and older can take it orally. Mothers who are positive for COVID can pass antibodies to their babies, protecting them. Children aged 6 months and older can receive the COVID vaccine. The initial dose may consist of 2 or 3 injections, depending on the brand. It is important to protect children against COVID, just like the flu. Manufacturers adjust the flu vaccine each year based on the important flu components. As flu season approaches, it is crucial to protect both seniors and children by practicing good hygiene and focusing on their well-being.

We are discussing regulation and the use of CRISPR to reduce mosquito populations and combat malaria. We are working with African countries on necessary trials. It will take time to get approvals, but the potential to eliminate disease locally is promising. Malaria is transmitted by mosquitoes, and we are demonstrating this by releasing some in the auditorium. Everyone should understand the impact, not just the poor.

The COVID-19 vaccines have proven to be highly effective in the real world. Both the mRNA vaccine and another vaccine have shown efficacy rates of 94% to 95% for mild to moderate disease. In fact, the real world effectiveness of these vaccines is even more impressive than the results of the clinical trials. It is clear that these vaccines are highly effective in preventing COVID-19.

We cannot afford to trust WHO anymore, and several issues have caused great concern. In 2014 and 2015, WHO brought a tetanus eradication campaign to Kenya focused on eradicating neonatal tetanus—tetanus in babies after birth. The vaccine used was described as a different type of tetanus vaccine: tetanus combined with the hormone human chorionic gonadotropin (hCG), which “supports pregnancy.” The claim is that when injected into a woman, the vaccine causes her to produce antibodies against the hormone, rendering her sterile. The speaker says this has been associated with an increase in infertility cases among young couples who are examined and found to be normal but cannot get children, as well as couples who lose three, four, or five pregnancies before carrying a pregnancy to term. The speaker says they were able to expose these concerns and published a paper available to others. The speaker adds that in 2017, WHO stated Kenya is now free of neonatal tetanus and left the country. The speaker further states that the vaccine was developed over a 20-year research period from 1972 to 1992 and that it was used in South America, and “it is possible it has been used in many other African countries.”

COVID-19 vaccines are described as safe and effective for various age groups, including children as young as five. Pfizer, Moderna, AstraZeneca, and Johnson & Johnson vaccines are highlighted. Studies and trials have confirmed the vaccines' safety and efficacy, with some showing high effectiveness in preventing symptomatic infections and severe disease. The FDA and European Medicines Agency have assessed and approved these vaccines. A booster shot different from the original vaccination is likely safe and effective. The vaccines are considered a key tool, along with mask-wearing and social distancing, to combat the spread of COVID-19 and return to normalcy.

We have a more effective vaccine this year compared to last year. It matches the current strains perfectly and has been proven safe with no reported side effects over the past three years.

The FDA approved Sanofi's meningococcal vaccine for infants aged six weeks to two years. According to the insert approved by the FDA, safety trials revealed serious adverse events (SAEs) in 5.3% of participants following MenQuadfi and 3.6% following Menveo during the study period. SAEs are defined as events with the potential to be fatal if unchecked. This suggests a rate of approximately one in twenty children experiencing a serious adverse event, a significantly higher rate than the previously claimed one in a million for vaccinations. The speaker questions the acceptability of this higher rate of adverse events.

Safe and effective vaccines have been developed and millions of doses are being delivered. The vaccines have been rigorously studied and proven to be safe and effective. Researchers have confirmed the safety and efficacy of various vaccines, including the Oxford AstraZeneca and Pfizer COVID-19 vaccines. Vaccination has been deemed safe and effective for children, with Pfizer's vaccine being 100% effective for kids aged 5 to 11. The European Medicines Agency has thoroughly assessed the vaccines and concluded they are safe and effective against COVID-19. The vaccines have undergone extensive testing and have been found to be extremely safe and effective. Overall, vaccines are considered safe, effective, and free.

Children aged 5 to 11 can now get the COVID vaccine to protect older and vulnerable individuals. The vaccine has low side effects, with only a few cases of heart inflammation out of millions vaccinated in the US. Getting COVID poses a higher risk of heart inflammation than the vaccine. Vaccinating kids can reduce school disruptions and help safeguard older people.

COVID-19 made us appreciate the freedom to be with loved ones. Vaccines protect and save lives from deadly diseases like polio and measles. However, 20 million children worldwide lack necessary vaccines. Don't wait, vaccinate yourself and your children. Together, we will overcome this with the help of vaccines.

FDA gave clearance to Sanofi Pasteur's MenQuadFi vaccine for meningococcal disease. Now you can give it to infants as young as six weeks old. serious adverse events affect five point three percent of participants. for every one hundred thousand infants, it affects between six and eight infants. So for every one hundred thousand infants that receive this, the serious adverse events can be fifty three thousand serious adverse events. That right there, guys, is supreme FDA logic. So make sure that you rush out and protect your infant and get that vaccine because, guys, we all know that vaccines are safe and effective.

Initially, all vaccines released under emergency use authorization by the FDA were considered outstanding. The J&J vaccine carries a risk of life-threatening blood clots. Despite claims that COVID poses zero threat to healthy children, vaccination for children was urged. Two mRNA vaccines were considered a three-dose vaccine. Two doses were found to be insufficient for emergency room visits and hospitalizations, necessitating a third immunization. A fourth immunization was suggested as a potential innovative solution. The numbers are trending up again, so a new bivalent booster is recommended for everyone ages 12 and older. Those over 50 who have had two boosters more than 2-4 months prior may need a third booster, a fifth immunization. Boosters may not be holding up as well as desired, potentially requiring boosters every few months. Disinformation campaigns have promoted fake concepts of herd immunity and discredited masks. Vaccinating is considered our last hope. The single most impactful thing is to be fully boosted, preferably twice boosted. Monkeypox is accelerating among men who have sex with men, though sources disagree on whether it is sexually transmitted.

Pfizer has announced that its coronavirus vaccine trial for adolescents aged 12 to 15 showed 100% effectiveness in preventing infection and illness. This significant finding could greatly impact the reopening of schools in America. Doctor Chris Purnell, a public health physician, noted that this efficacy rate is even higher than the 95% reported for adults. She emphasized that mRNA vaccines represent a groundbreaking advancement in technology, highlighting the promising results of the trial.

In 2022, over 14 million children did not receive any vaccines. The goal is to reduce that number by 2030, working with partners like Gavi and UNICEF. Anti-vaxxers pose a serious challenge, requiring a strategy to push back, because vaccines work for both children and adults, and there is evidence to support this. It's time to be more aggressive in countering anti-vaxxers, who used COVID as an opportunity to create havoc.

We conducted a study in Senegal to see how Ivermectin, given to people for river blindness, affected mosquitoes that transmit malaria. By catching mosquitoes before and after treatment, we found that the drug killed most adult mosquitoes, particularly the ones that transmit malaria. Although the total number of mosquitoes didn't decrease significantly, the drug effectively eliminated the old females responsible for spreading malaria.

Researchers at the Bill Gates Foundation-backed Leiden University Medical Center are developing genetically modified mosquitoes to deliver malaria vaccines. A recent study showed that 8 out of 9 participants who received bites from one type of modified mosquito were protected against malaria, while those in the placebo group received no protection. Despite safety concerns and ethical issues regarding informed consent, the research continues, with plans for larger trials and potential applications for other diseases. Meanwhile, an Australian regulatory body is reviewing an application to release genetically modified mosquitoes to combat dengue fever. The implications of using insects as vaccine carriers raise significant ethical questions, and there are ongoing calls for accountability regarding these experiments.

New vaccines for tuberculosis, malaria, HIV, and COVID-19 are being developed. These vaccines aim to have longer-lasting effects and wider coverage. In addition, instead of using needles, a patch will be used for administration. The COVID-19 pandemic has brought attention to the fact that we have not invested enough in these innovative advancements.